Zymeworks Inc. (ZYME) stock

ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value

$26.47−2.60 (-8.94%)

Close on Nov 12, 2026Market cap $1.88BP/E 50.9Yield –

Zymeworks EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Zymeworks's EPS for the twelve months ending Sep 30, 2026 was $0.52. For fiscal 2025 it was -$1.08. The highest annual figure on record is $1.90 in fiscal 2022.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$1.08	–
FY2024	Dec 31, 2024	-$1.62	–
FY2023	Dec 31, 2023	-$1.72	-190.5%
FY2022	Dec 31, 2022	$1.90	–
FY2021	Dec 31, 2021	-$4.61	–
FY2020	Dec 31, 2020	-$3.58	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$2.28	–
Q2 FY2026	Jun 30, 2026	-$0.62	-2166.7%
Q1 FY2026	Mar 31, 2026	-$0.59	–
Q4 FY2025	Dec 31, 2025	-$0.55	–
Q3 FY2025	Sep 30, 2025	-$0.26	–
Q2 FY2025	Jun 30, 2025	$0.03	–
Q1 FY2025	Mar 31, 2025	-$0.30	–
Q4 FY2024	Dec 31, 2024	-$0.31	–
Q3 FY2024	Sep 30, 2024	-$0.39	–
Q2 FY2024	Jun 30, 2024	-$0.49	–
Q1 FY2024	Mar 31, 2024	-$0.42	–
Q4 FY2023	Dec 31, 2023	-$0.20	-104.3%
Q3 FY2023	Sep 30, 2023	-$0.41	–
Q2 FY2023	Jun 30, 2023	-$0.76	–
Q1 FY2023	Mar 31, 2023	-$0.37	–
Q4 FY2022	Dec 31, 2022	$4.64	–
Q3 FY2022	Sep 30, 2022	-$0.72	–
Q2 FY2022	Jun 30, 2022	-$0.97	–
Q1 FY2022	Mar 31, 2022	-$1.19	–
Q4 FY2021	Dec 31, 2021	-$0.75	–
Q3 FY2021	Sep 30, 2021	-$1.25	–